Could a single pill replace two? early study tests combo drug
NCT ID NCT07622433
First seen Jun 15, 2026 · Last updated Jun 22, 2026 · Updated 2 times
Summary
This early-stage trial is testing whether a single tablet containing both laroprovstat and ezetimibe works as well as taking the two drugs separately. The study involves 18 healthy adults who will receive different pill combinations in random order. Researchers will measure how the drugs are absorbed and processed by the body, and whether food affects absorption. The goal is to see if a combined pill is a viable option for future use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGBrooklyn, Maryland, 21225, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Laroprovstat and ezetimibe (combined and separate tablets)
What this could lead to
If successful, this could lead to a single pill that simplifies taking both drugs together, potentially improving convenience for future patients.
What could go wrong
This is a very early Phase 1 study in only 18 healthy people. It only checks how the body handles the drugs, not if they work for any disease. Results may not apply to patients.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.